Adverse reactions of BNT162b2 vaccine booster against COVID‐19 in Japan
Toshinori Nishizawa, Torahiko Jinta, Ryosuke Koyamada and 3 more
Journal of General and Family Medicine · 2022
doi:10.1002/jgf2.545 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Female participants had a higher incidence of headache, nausea, myalgia, arthralgia, redness, pruritus, and inoculation site redness and pruritus (p 0.05). Low grade fever, headache, malaise, myalgia, and inoculation site induration and heat were associated with age group (p 0.05).
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.